Abstract:Paeonia delavayi (Paeoniaceae), an endemic plant mainly distributed in southwest China, is always used as the substitute of P. suffruticosa due to their morphological and pharmacological similarity. In the previous study, P. suffruticosa was revealed with antidiabetic potency, whereas the chemical difference and antidiabetic property between different parts of P. delavayi has not yet been studied. This paper was designed to clarify the chemical constituents and antidiabetic potency of P. delavayi by LCMS analysis and enzyme inhibition on α-glucosidase, PTP1B, TCPTP, and DPP4. By interpretation of their UV absorptions and MS fragmentations, and/or comparison with reference samples, 57 constituents comprising 15 flavonoids, 10 monoterpene glycosides, eight triterpenoids, seven galloyl glucoses, six N-containing compounds, five gallic acids, two acetophenones, and four other types of compounds were identified from the different parts of P. delavayi. Moreover, two new monoterpene aglycones (42 and 47) and one new noroleanane triterpenoid (51) were speculated by their MS/MS fragmentation rules. Principal component analysis (PCA) suggested the chemical resemblance between root core and root bark which could be well differentiated with the leaves and stems by their characteristic constituents (monoterpene glycosides, flavonoids, and acetophenones). All the four parts (200 μg/mL) showed obvious inhibition on α-glucosidase and PTP1B (81.2% to 98.5%), but moderate to weak inhibition on TCPTP and DPP4 (19.5% to 34.9%). Nine compounds representing five main types of constituents in Paeonia plants were assayed for their antidiabetic effects, indicating flavonoids and triterpenoids were the main active substances regarding to the four enzymes. Luteolin displayed obvious activity on α-glucosidase, PTP1B, and TCPTP with IC50 values of 94.6, 136.3, and 157.3 μM, and akebonic acid could inhibit α-glucosidase and PTP1B with IC50 values of 73.5 and 57.8 μM. Luteolin and akebonic acid were recognized as competitive inhibitors of α-glucosidase, but anticompetitive and mix-type inhibitors of PTP1B, respectively. Docking study demonstrated akebonic acid as PTP1B (over TCPTP) selective inhibitor by bonding to the catalytic sites (B/C) of PTP1B. This LCMS combined with enzymatic comparison opens new sights for recognizing the chemical profiles and antidiabetic potency of P. delavayi.

A New 24,30-Dinortriterpenoid From Paeonia Delavayi

A New 24, 30-Dinortriterpenoid from Paeonia Delavayi

Oleanane‐Type Triterpenoids from the Endophytic Fungus Pestalotiopsis Clavispora Isolated from the Chinese Mangrove Plant Bruguiera Sexangula

Paeonone A, a novel nonanortriterpenoid from the roots of Paeonia lactiflora

Two new monoterpene glucosides from Paeonia lactiflora Pall.

Two New 18-Norschiartane-type Schinortriterpenoids from Schisandra lancifolia.

Three new monoterpene glycosides from the roots of Paeonia lactiflora.

A New Triterpenoid From Teucrium Viscidum

A new phenolic glycoside from Paeonia lactiflora

Chemical profiling and antidiabetic potency of Paeonia delavayi: Comparison between different parts and constituents

[A new paeoniflorin derivative isolated from the root bark ethanol extract of Paeonia suffruticosa]

Lancolides, antiplatelet aggregation nortriterpenoids with tricyclo[6.3.0.02,11]undecane-bridged system from Schisandra lancifolia

Four New Lignans from the Leaves and Stems of Schisandra Propinqua Var. Sinensis

A New Prenylated Flavone from Pleione Bulbocodioides

[A new monoterpene glycoside from active fraction (DSS-A-N-30) of Danggui Shaoyao San]

Two new triterpenoids from the carpophore of Xanthoceras sorbifolia Bunge.

A new monoterpene glycoside and antibacterial monoterpene glycosides from Paeonia suffruticosa

A new triterpenoid and a new glycoside from Pilea cavaleriei.

[A new sesquiterpene from Syringa oblata]

[Study on chemical constituents of bark of Paeonia suffruticosa]

Secondary Metabolites from Viburnum Erosum